Document is current
Any future updates will be listed below
-
Authors
Beck, Christina
Ramanujam, Deepak https://orcid.org/0000-0003-4854-6355
Vaccarello, Paula https://orcid.org/0000-0002-0452-4712
Widenmeyer, Florenc https://orcid.org/0000-0002-6968-9147
Feuerherd, Martin
Cheng, Cho-Chin
Bomhard, Anton
Abikeeva, Tatiana
Schädler, Julia
Sperhake, Jan-Peter
Graw, Matthias
Safi, Seyer
Hoffmann, Hans
Staab-Weijnitz, Claudia A. https://orcid.org/0000-0002-1211-7834
Rad, Roland https://orcid.org/0000-0002-6849-9659
Protzer, Ulrike https://orcid.org/0000-0002-9421-1911
Frischmuth, Thomas
Engelhardt, Stefan https://orcid.org/0000-0001-5378-8661
- License Information
-
More Information
Article History
Received: 23 December 2022
Accepted: 18 July 2023
First Online: 28 July 2023
Competing interests
: Technical University of Munich has filed an intellectual property right on the therapeutic use of mannose-coupled antimiR-21 with D.R. and S.E. named as inventors. S.E. and T.F. are founders of RNATICS GmbH, a biotech company focussed on macrophage RNA therapeutics. After the completion of this study, D.R. joined RNATICS GmbH. Other authors do not have any conflicts.
